Table 3: Presentation of significant differences of OSAS indices, inflammatory mediators, and selected lymphocyte subpopulations between patients in relation to obesity and metabolic syndrome.

Obesity
()
Nonobese
()
MS
()
Without MS
()

AHIh−162.7
39.4–71.6
42.4
34.0–51.3
0.00246
39–72
46
34–63
NS

SpO2 min%74.0
67.0–79.0
81.0
78.5–85.5
0.000275
68–80
80
77–82
0.038

CRPmg/dL3.6
1.4–7.1
1.0
0.6–2.2
0.0023.6
1.6–5.5
1
0.6–2.1
0.002

WBC×103/L7.4
6.0–9.1
6.5
5.6–7.2
0.046.9
6–8.9
6.7
5.3–7.4
NS

Lymphocytes B %6.5
5.4–8.5
10.5
6.4–12.4
0.0057.0
5.4–10
9.6
6.7–12.4
NS

NK cells/L333
244–474
209
126–294
0.006329
209–474
258
149–337
0.03

NKT-like cells/L111
58–195
55
32–123
0.02103
52–183
88
35–179
NS

CD3+/HLA DR+/L149
85–242
113
55–158
0.03162
81–245
113
68–153
NS

AHI: apnea/hypopnea index; SpO2: peripheral capillary oxygen saturation; WBC: white blood cells; MS: metabolic syndrome.